DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: For currently untreatable dysferlinopathy, exosomes from myotubes or human serum act as potent nanocarriers, delivering full-length dysferlin gene/protein to deficient fibers and restoring dysferlin expression, offering a novel therapeutic avenue [103].